HIGHLIGHTS
- who: R-TB and colleagues from the for MDR-TBThe previous study showed impaired Th, responses and enhanced regulatory, cell levels in circulatory blood of MDRTB patients. The study of , represented anti-inflammation cytokine as immune suppression never been conducted in Indonesia have published the Article: Interleukin-10, in the Journal: (JOURNAL)
- how: Data showed that all the history of treatment classification dominated by patients with the low level of IL-10.
SUMMARY
Penelitian oleh Geffner dkk memperlihatkan peranan sel Th1, yang merupakan pola respons imun utama melawan M.tb, terganggu . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.